Geriatric Medicines Market size is expected to grow at a CAGR of 7% during the forecast period and the market size is expected to reach nearly USD 1.8 Billion by 2029. Geriatrics is a division of medicines related to the remedial, clinical, social, and preventive aspects of ill health generally among the population over & above 65 years. The majority of the geriatrics is not capable to take their medication accurately at the planned time on account of complex psychological and medical issues. The geriatric population needs special attention and care for the rapid revival of disorder or disease.To know about the Research Methodology:-Request Free Sample Report The growing number of the aging population is a major factor driving the growth of the global geriatric medicines market. In addition, increasing the incidence of chronic diseases and demand for effective therapy is another factor fueling the growth of the global geriatric medicines market. Furthermore, rapidly developing medical infrastructure, government initiatives, rising health care per person expenditure are also factors expected to drive revenue growth of the global geriatric medicines market. However, the dearth of wakefulness about the accessibility of geriatric care among aged patients in budding countries is a critical factor expected to hamper the market growth. The report covers the latest trends in the geriatric medicines market such as the government are funding several R&D activities in order to conduct clinical trials for the development of effective treatment procedures. In addition, the government is coming up with different reimbursement policies that are beneficial for the aging population for managing the cost of treatment. On the basis of the therapeutic category, the antihypertensive segment is expected to dominate the global geriatric medicines market in terms of revenue and expected to maintain its position in the future. This can be primarily attributed to the rising incidences of hypertension among the elderly populace. Region-wise, the market in North America accounts for a major share of XX% in terms of revenue and is expected to lucrative growth over the forecast period. The growing number of people above 65 age coupled with rising occurrences of age-related disorder and diseases are the factors expected to drive the growth of the geriatric medicines market in countries in the region. Asia Pacific market is expected to witness the fastest growth in terms of revenue over the forecast period. The objective of the report is to present a comprehensive analysis of the Global Geriatric Medicines Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Application. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Application on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Geriatric Medicines Market dynamics, structure by analyzing the market segments and project the Global Geriatric Medicines Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Geriatric Medicines Market make the report investor’s guide. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Geriatric Medicines Market Scope: Inquire before buying
Global Geriatric Medicines Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.06 Bn. Forecast Period 2022 to 2029 CAGR: 7% Market Size in 2029: US $ 1.8 Bn. Segments Covered: by Therapeutic Category • Analgesic • Antihypertensive • Statins • Antidiabetic • Proton Pump Inhibitor • Anticoagulant • Antipsychotic and Antidepressant • Others (include, anticholinergics, gastrointestinal, etc.) by Conditions • Cardiovascular • Arthritis • Diabetes • Neurological • Cancer • Osteoporosis • Respiratory • Others (include, Parkinson's disease, palliative care, etc.) by Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Geriatric Medicines Market By Region
• North America • Europe • Asia Pacific • Middle East and Africa • South AmericaGeriatric Medicines Market Key Players
• Pfizer, Inc. • Merck & Co., Inc. • AstraZeneca plc • Bristol-Myers Squibb Company • Novartis AG • Sanofi S.A • GlaxoSmithKline plc • Eli Lilly and Company • Abbott Laboratories • Boehringer Ingelheim GmbH • Allergan Inc. • Endo Pharmaceuticals Inc. • Otsuka Pharmaceutical Co., Ltd • Dr. Reddy's Laboratories Ltd • Sun Pharmaceutical Industries Ltd • Mylan N.V. • Aurobindo Pharma Frequently Asked Questions: 1. Which region has the largest share in Global Geriatric Medicines Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Geriatric Medicines Market? Ans: The Global Geriatric Medicines Market is growing at a CAGR of 7% during forecasting period 2022-2029. 3. What is scope of the Global Geriatric Medicines market report? Ans: Global Geriatric Medicines Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Geriatric Medicines market? Ans: The important key players in the Global Geriatric Medicines Market are – Pfizer, Inc., Merck & Co., Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A, GlaxoSmithKline plc, Eli Lilly and Company, Abbott Laboratories, Boehringer Ingelheim GmbH, Allergan Inc., Endo Pharmaceuticals Inc., Otsuka Pharmaceutical Co., Ltd, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Aurobindo Pharma, and 5. What is the study period of this market? Ans: The Global Geriatric Medicines Market is studied from 2021 to 2029.
Global Geriatric Medicines Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Geriatric Medicines Market, By Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Statins Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Geriatric Medicines Market Analysis and Forecast 6.1. Global Geriatric Medicines Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Geriatric Medicines Market Analysis and Forecast, By Therapeutic Category 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 7.4. Global Geriatric Medicines Market Size (US$ Bn) Forecast, By Therapeutic Category 7.5. Global Geriatric Medicines Market Analysis, By Therapeutic Category 7.6. Global Geriatric Medicines Market Attractiveness Analysis, By Therapeutic Category 8. Global Geriatric Medicines Market Analysis and Forecast, By Condition 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Geriatric Medicines Market Value Share Analysis, By Condition 8.4. Global Geriatric Medicines Market Size (US$ Bn) Forecast, By Condition 8.5. Global Geriatric Medicines Market Analysis, By Condition 8.6. Global Geriatric Medicines Market Attractiveness Analysis, By Condition 9. Global Geriatric Medicines Market Analysis and Forecast, By Distribution Channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Geriatric Medicines Market Value Share Analysis, By Distribution Channel 9.4. Global Geriatric Medicines Market Size (US$ Bn) Forecast, By Distribution Channel 9.5. Global Geriatric Medicines Market Analysis, By Distribution Channel 9.6. Global Geriatric Medicines Market Attractiveness Analysis, By Distribution Channel 10. Global Geriatric Medicines Market Analysis, By Region 10.1. Global Geriatric Medicines Market Value Share Analysis, By Region 10.2. Global Geriatric Medicines Market Size (US$ Bn) Forecast, By Region 10.3. Global Geriatric Medicines Market Attractiveness Analysis, By Region 11. North America Geriatric Medicines Market Analysis 11.1. Key Findings 11.2. North America Geriatric Medicines Market Overview 11.3. North America Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 11.4. North America Geriatric Medicines Market Forecast, By Therapeutic Category 11.4.1. Analgesic 11.4.2. Antihypertensive 11.4.3. Statins 11.4.4. Antidiabetic 11.4.5. Proton Pump Inhibitor 11.4.6. Anticoagulant 11.4.7. Antipsychotic and Antidepressant 11.4.8. Others (include, anticholinergics, gastrointestinal, etc.) 11.5. North America Geriatric Medicines Market Value Share Analysis, By Condition 11.6. North America Geriatric Medicines Market Forecast, By Condition 11.6.1. Cardiovascular 11.6.2. Arthritis 11.6.3. Diabetes 11.6.4. Neurological 11.6.5. Cancer 11.6.6. Osteoporosis 11.6.7. Respiratory 11.6.8. Others (include, Parkinson's disease, palliative care, etc.) 11.7. North America Geriatric Medicines Market Value Share Analysis, By Distribution Channel 11.8. North America Geriatric Medicines Market Forecast, By Distribution Channel 11.8.1. Hospital Pharmacies 11.8.2. Retail Pharmacies 11.8.3. Online Pharmacies 11.9. North America Geriatric Medicines Market Value Share Analysis, By Country 11.10. North America Geriatric Medicines Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Geriatric Medicines Market Analysis, By Country 11.12. U.S. Geriatric Medicines Market Forecast, By Therapeutic Category 11.12.1. Analgesic 11.12.2. Antihypertensive 11.12.3. Statins 11.12.4. Antidiabetic 11.12.5. Proton Pump Inhibitor 11.12.6. Anticoagulant 11.12.7. Antipsychotic and Antidepressant 11.12.8. Others (include, anticholinergics, gastrointestinal, etc.) 11.13. U.S. Geriatric Medicines Market Forecast, By Condition 11.13.1. Cardiovascular 11.13.2. Arthritis 11.13.3. Diabetes 11.13.4. Neurological 11.13.5. Cancer 11.13.6. Osteoporosis 11.13.7. Respiratory 11.13.8. Others (include, Parkinson's disease, palliative care, etc.) 11.14. U.S. Geriatric Medicines Market Forecast, By Distribution Channel 11.14.1. Hospital Pharmacies 11.14.2. Retail Pharmacies 11.14.3. Online Pharmacies 11.15. Canada Geriatric Medicines Market Forecast, By Therapeutic Category 11.15.1. Analgesic 11.15.2. Antihypertensive 11.15.3. Statins 11.15.4. Antidiabetic 11.15.5. Proton Pump Inhibitor 11.15.6. Anticoagulant 11.15.7. Antipsychotic and Antidepressant 11.15.8. Others (include, anticholinergics, gastrointestinal, etc.) 11.16. Canada Geriatric Medicines Market Forecast, By Condition 11.16.1. Cardiovascular 11.16.2. Arthritis 11.16.3. Diabetes 11.16.4. Neurological 11.16.5. Cancer 11.16.6. Osteoporosis 11.16.7. Respiratory 11.16.8. Others (include, Parkinson's disease, palliative care, etc.) 11.17. Canada Geriatric Medicines Market Forecast, By Distribution Channel 11.17.1. Hospital Pharmacies 11.17.2. Retail Pharmacies 11.17.3. Online Pharmacies 11.18. North America Geriatric Medicines Market Attractiveness Analysis 11.18.1. By Therapeutic Category 11.18.2. By Condition 11.18.3. By Distribution Channel 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Geriatric Medicines Market Analysis 12.1. Key Findings 12.2. Europe Geriatric Medicines Market Overview 12.3. Europe Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 12.4. Europe Geriatric Medicines Market Forecast, By Therapeutic Category 12.4.1. Analgesic 12.4.2. Antihypertensive 12.4.3. Statins 12.4.4. Antidiabetic 12.4.5. Proton Pump Inhibitor 12.4.6. Anticoagulant 12.4.7. Antipsychotic and Antidepressant 12.4.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.5. Europe Geriatric Medicines Market Value Share Analysis, By Condition 12.6. Europe Geriatric Medicines Market Forecast, By Condition 12.6.1. Cardiovascular 12.6.2. Arthritis 12.6.3. Diabetes 12.6.4. Neurological 12.6.5. Cancer 12.6.6. Osteoporosis 12.6.7. Respiratory 12.6.8. Others (include, Parkinson's disease, palliative care, etc.) 12.7. Europe Geriatric Medicines Market Value Share Analysis, By Distribution Channel 12.8. Europe Geriatric Medicines Market Forecast, By Distribution Channel 12.8.1. Hospital Pharmacies 12.8.2. Retail Pharmacies 12.8.3. Online Pharmacies 12.9. Europe Geriatric Medicines Market Value Share Analysis, By Country 12.10. Europe Geriatric Medicines Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Geriatric Medicines Market Analysis, By Country 12.12. Germany Geriatric Medicines Market Forecast, By Therapeutic Category 12.12.1. Analgesic 12.12.2. Antihypertensive 12.12.3. Statins 12.12.4. Antidiabetic 12.12.5. Proton Pump Inhibitor 12.12.6. Anticoagulant 12.12.7. Antipsychotic and Antidepressant 12.12.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.13. Germany Geriatric Medicines Market Forecast, By Condition 12.13.1. Cardiovascular 12.13.2. Arthritis 12.13.3. Diabetes 12.13.4. Neurological 12.13.5. Cancer 12.13.6. Osteoporosis 12.13.7. Respiratory 12.13.8. Others (include, Parkinson's disease, palliative care, etc.) 12.14. Germany Geriatric Medicines Market Forecast, By Distribution Channel 12.14.1. Hospital Pharmacies 12.14.2. Retail Pharmacies 12.14.3. Online Pharmacies 12.15. U.K. Geriatric Medicines Market Forecast, By Therapeutic Category 12.15.1. Analgesic 12.15.2. Antihypertensive 12.15.3. Statins 12.15.4. Antidiabetic 12.15.5. Proton Pump Inhibitor 12.15.6. Anticoagulant 12.15.7. Antipsychotic and Antidepressant 12.15.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.16. U.K. Geriatric Medicines Market Forecast, By Condition 12.16.1. Cardiovascular 12.16.2. Arthritis 12.16.3. Diabetes 12.16.4. Neurological 12.16.5. Cancer 12.16.6. Osteoporosis 12.16.7. Respiratory 12.16.8. Others (include, Parkinson's disease, palliative care, etc.) 12.17. U.K. Geriatric Medicines Market Forecast, By Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Retail Pharmacies 12.17.3. Online Pharmacies 12.18. France Geriatric Medicines Market Forecast, By Therapeutic Category 12.18.1. Analgesic 12.18.2. Antihypertensive 12.18.3. Statins 12.18.4. Antidiabetic 12.18.5. Proton Pump Inhibitor 12.18.6. Anticoagulant 12.18.7. Antipsychotic and Antidepressant 12.18.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.19. France Geriatric Medicines Market Forecast, By Condition 12.19.1. Cardiovascular 12.19.2. Arthritis 12.19.3. Diabetes 12.19.4. Neurological 12.19.5. Cancer 12.19.6. Osteoporosis 12.19.7. Respiratory 12.19.8. Others (include, Parkinson's disease, palliative care, etc.) 12.20. France Geriatric Medicines Market Forecast, By Distribution Channel 12.20.1. Hospital Pharmacies 12.20.2. Retail Pharmacies 12.20.3. Online Pharmacies 12.21. Italy Geriatric Medicines Market Forecast, By Therapeutic Category 12.21.1. Analgesic 12.21.2. Antihypertensive 12.21.3. Statins 12.21.4. Antidiabetic 12.21.5. Proton Pump Inhibitor 12.21.6. Anticoagulant 12.21.7. Antipsychotic and Antidepressant 12.21.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.22. Italy Geriatric Medicines Market Forecast, By Condition 12.22.1. Cardiovascular 12.22.2. Arthritis 12.22.3. Diabetes 12.22.4. Neurological 12.22.5. Cancer 12.22.6. Osteoporosis 12.22.7. Respiratory 12.22.8. Others (include, Parkinson's disease, palliative care, etc.) 12.23. Italy Geriatric Medicines Market Forecast, By Distribution Channel 12.23.1. Hospital Pharmacies 12.23.2. Retail Pharmacies 12.23.3. Online Pharmacies 12.24. Spain Geriatric Medicines Market Forecast, By Therapeutic Category 12.24.1. Analgesic 12.24.2. Antihypertensive 12.24.3. Statins 12.24.4. Antidiabetic 12.24.5. Proton Pump Inhibitor 12.24.6. Anticoagulant 12.24.7. Antipsychotic and Antidepressant 12.24.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.25. Spain Geriatric Medicines Market Forecast, By Condition 12.25.1. Cardiovascular 12.25.2. Arthritis 12.25.3. Diabetes 12.25.4. Neurological 12.25.5. Cancer 12.25.6. Osteoporosis 12.25.7. Respiratory 12.25.8. Others (include, Parkinson's disease, palliative care, etc.) 12.26. Spain Geriatric Medicines Market Forecast, By Distribution Channel 12.26.1. Hospital Pharmacies 12.26.2. Retail Pharmacies 12.26.3. Online Pharmacies 12.27. Rest of Europe Geriatric Medicines Market Forecast, By Therapeutic Category 12.27.1. Analgesic 12.27.2. Antihypertensive 12.27.3. Statins 12.27.4. Antidiabetic 12.27.5. Proton Pump Inhibitor 12.27.6. Anticoagulant 12.27.7. Antipsychotic and Antidepressant 12.27.8. Others (include, anticholinergics, gastrointestinal, etc.) 12.28. Rest of Europe Geriatric Medicines Market Forecast, By Condition 12.28.1. Cardiovascular 12.28.2. Arthritis 12.28.3. Diabetes 12.28.4. Neurological 12.28.5. Cancer 12.28.6. Osteoporosis 12.28.7. Respiratory 12.28.8. Others (include, Parkinson's disease, palliative care, etc.) 12.29. Rest of Europe Geriatric Medicines Market Forecast, By Distribution Channel 12.29.1. Hospital Pharmacies 12.29.2. Retail Pharmacies 12.29.3. Online Pharmacies 12.30. Europe Geriatric Medicines Market Attractiveness Analysis 12.30.1. By Therapeutic Category 12.30.2. By Condition 12.30.3. By Distribution Channel 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Geriatric Medicines Market Analysis 13.1. Key Findings 13.2. Asia Pacific Geriatric Medicines Market Overview 13.3. Asia Pacific Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 13.4. Asia Pacific Geriatric Medicines Market Forecast, By Therapeutic Category 13.4.1. Analgesic 13.4.2. Antihypertensive 13.4.3. Statins 13.4.4. Antidiabetic 13.4.5. Proton Pump Inhibitor 13.4.6. Anticoagulant 13.4.7. Antipsychotic and Antidepressant 13.4.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.5. Asia Pacific Geriatric Medicines Market Value Share Analysis, By Condition 13.6. Asia Pacific Geriatric Medicines Market Forecast, By Condition 13.6.1. Cardiovascular 13.6.2. Arthritis 13.6.3. Diabetes 13.6.4. Neurological 13.6.5. Cancer 13.6.6. Osteoporosis 13.6.7. Respiratory 13.6.8. Others (include, Parkinson's disease, palliative care, etc.) 13.7. Asia Pacific Geriatric Medicines Market Value Share Analysis, By Distribution Channel 13.8. Asia Pacific Geriatric Medicines Market Forecast, By Distribution Channel 13.8.1. Hospital Pharmacies 13.8.2. Retail Pharmacies 13.8.3. Online Pharmacies 13.9. Asia Pacific Geriatric Medicines Market Value Share Analysis, By Country 13.10. Asia Pacific Geriatric Medicines Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Geriatric Medicines Market Analysis, By Country 13.12. China Geriatric Medicines Market Forecast, By Therapeutic Category 13.12.1. Analgesic 13.12.2. Antihypertensive 13.12.3. Statins 13.12.4. Antidiabetic 13.12.5. Proton Pump Inhibitor 13.12.6. Anticoagulant 13.12.7. Antipsychotic and Antidepressant 13.12.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.13. China Geriatric Medicines Market Forecast, By Condition 13.13.1. Cardiovascular 13.13.2. Arthritis 13.13.3. Diabetes 13.13.4. Neurological 13.13.5. Cancer 13.13.6. Osteoporosis 13.13.7. Respiratory 13.13.8. Others (include, Parkinson's disease, palliative care, etc.) 13.14. China Geriatric Medicines Market Forecast, By Distribution Channel 13.14.1. Hospital Pharmacies 13.14.2. Retail Pharmacies 13.14.3. Online Pharmacies 13.15. India Geriatric Medicines Market Forecast, By Therapeutic Category 13.15.1. Analgesic 13.15.2. Antihypertensive 13.15.3. Statins 13.15.4. Antidiabetic 13.15.5. Proton Pump Inhibitor 13.15.6. Anticoagulant 13.15.7. Antipsychotic and Antidepressant 13.15.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.16. India Geriatric Medicines Market Forecast, By Condition 13.16.1. Cardiovascular 13.16.2. Arthritis 13.16.3. Diabetes 13.16.4. Neurological 13.16.5. Cancer 13.16.6. Osteoporosis 13.16.7. Respiratory 13.16.8. Others (include, Parkinson's disease, palliative care, etc.) 13.17. India Geriatric Medicines Market Forecast, By Distribution Channel 13.17.1. Hospital Pharmacies 13.17.2. Retail Pharmacies 13.17.3. Online Pharmacies 13.18. Japan Geriatric Medicines Market Forecast, By Therapeutic Category 13.18.1. Analgesic 13.18.2. Antihypertensive 13.18.3. Statins 13.18.4. Antidiabetic 13.18.5. Proton Pump Inhibitor 13.18.6. Anticoagulant 13.18.7. Antipsychotic and Antidepressant 13.18.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.19. Japan Geriatric Medicines Market Forecast, By Condition 13.19.1. Cardiovascular 13.19.2. Arthritis 13.19.3. Diabetes 13.19.4. Neurological 13.19.5. Cancer 13.19.6. Osteoporosis 13.19.7. Respiratory 13.19.8. Others (include, Parkinson's disease, palliative care, etc.) 13.20. Japan Geriatric Medicines Market Forecast, By Distribution Channel 13.20.1. Hospital Pharmacies 13.20.2. Retail Pharmacies 13.20.3. Online Pharmacies 13.21. ASEAN Geriatric Medicines Market Forecast, By Therapeutic Category 13.21.1. Analgesic 13.21.2. Antihypertensive 13.21.3. Statins 13.21.4. Antidiabetic 13.21.5. Proton Pump Inhibitor 13.21.6. Anticoagulant 13.21.7. Antipsychotic and Antidepressant 13.21.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.22. ASEAN Geriatric Medicines Market Forecast, By Condition 13.22.1. Cardiovascular 13.22.2. Arthritis 13.22.3. Diabetes 13.22.4. Neurological 13.22.5. Cancer 13.22.6. Osteoporosis 13.22.7. Respiratory 13.22.8. Others (include, Parkinson's disease, palliative care, etc.) 13.23. ASEAN Geriatric Medicines Market Forecast, By Distribution Channel 13.23.1. Hospital Pharmacies 13.23.2. Retail Pharmacies 13.23.3. Online Pharmacies 13.24. Rest of Asia Pacific Geriatric Medicines Market Forecast, By Therapeutic Category 13.24.1. Analgesic 13.24.2. Antihypertensive 13.24.3. Statins 13.24.4. Antidiabetic 13.24.5. Proton Pump Inhibitor 13.24.6. Anticoagulant 13.24.7. Antipsychotic and Antidepressant 13.24.8. Others (include, anticholinergics, gastrointestinal, etc.) 13.25. Rest of Asia Pacific Geriatric Medicines Market Forecast, By Condition 13.25.1. Cardiovascular 13.25.2. Arthritis 13.25.3. Diabetes 13.25.4. Neurological 13.25.5. Cancer 13.25.6. Osteoporosis 13.25.7. Respiratory 13.25.8. Others (include, Parkinson's disease, palliative care, etc.) 13.26. Rest of Asia Pacific Geriatric Medicines Market Forecast, By Distribution Channel 13.26.1. Hospital Pharmacies 13.26.2. Retail Pharmacies 13.26.3. Online Pharmacies 13.27. Asia Pacific Geriatric Medicines Market Attractiveness Analysis 13.27.1. By Therapeutic Category 13.27.2. By Condition 13.27.3. By Distribution Channel 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Geriatric Medicines Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Geriatric Medicines Market Overview 14.3. Middle East & Africa Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 14.4. Middle East & Africa Geriatric Medicines Market Forecast, By Therapeutic Category 14.4.1. Analgesic 14.4.2. Antihypertensive 14.4.3. Statins 14.4.4. Antidiabetic 14.4.5. Proton Pump Inhibitor 14.4.6. Anticoagulant 14.4.7. Antipsychotic and Antidepressant 14.4.8. Others (include, anticholinergics, gastrointestinal, etc.) 14.5. Middle East & Africa Geriatric Medicines Market Value Share Analysis, By Condition 14.6. Middle East & Africa Geriatric Medicines Market Forecast, By Condition 14.6.1. Cardiovascular 14.6.2. Arthritis 14.6.3. Diabetes 14.6.4. Neurological 14.6.5. Cancer 14.6.6. Osteoporosis 14.6.7. Respiratory 14.6.8. Others (include, Parkinson's disease, palliative care, etc.) 14.7. Middle East & Africa Geriatric Medicines Market Value Share Analysis, By Distribution Channel 14.8. Middle East & Africa Geriatric Medicines Market Forecast, By Distribution Channel 14.8.1. Hospital Pharmacies 14.8.2. Retail Pharmacies 14.8.3. Online Pharmacies 14.9. Middle East & Africa Geriatric Medicines Market Value Share Analysis, By Country 14.10. Middle East & Africa Geriatric Medicines Market Forecast, By Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Geriatric Medicines Market Analysis, By Country 14.12. GCC Geriatric Medicines Market Forecast, By Therapeutic Category 14.12.1. Analgesic 14.12.2. Antihypertensive 14.12.3. Statins 14.12.4. Antidiabetic 14.12.5. Proton Pump Inhibitor 14.12.6. Anticoagulant 14.12.7. Antipsychotic and Antidepressant 14.12.8. Others (include, anticholinergics, gastrointestinal, etc.) 14.13. GCC Geriatric Medicines Market Forecast, By Condition 14.13.1. Cardiovascular 14.13.2. Arthritis 14.13.3. Diabetes 14.13.4. Neurological 14.13.5. Cancer 14.13.6. Osteoporosis 14.13.7. Respiratory 14.13.8. Others (include, Parkinson's disease, palliative care, etc.) 14.14. GCC Geriatric Medicines Market Forecast, By Distribution Channel 14.14.1. Hospital Pharmacies 14.14.2. Retail Pharmacies 14.14.3. Online Pharmacies 14.15. South Africa Geriatric Medicines Market Forecast, By Therapeutic Category 14.15.1. Analgesic 14.15.2. Antihypertensive 14.15.3. Statins 14.15.4. Antidiabetic 14.15.5. Proton Pump Inhibitor 14.15.6. Anticoagulant 14.15.7. Antipsychotic and Antidepressant 14.15.8. Others (include, anticholinergics, gastrointestinal, etc.) 14.16. South Africa Geriatric Medicines Market Forecast, By Condition 14.16.1. Cardiovascular 14.16.2. Arthritis 14.16.3. Diabetes 14.16.4. Neurological 14.16.5. Cancer 14.16.6. Osteoporosis 14.16.7. Respiratory 14.16.8. Others (include, Parkinson's disease, palliative care, etc.) 14.17. South Africa Geriatric Medicines Market Forecast, By Distribution Channel 14.17.1. Hospital Pharmacies 14.17.2. Retail Pharmacies 14.17.3. Online Pharmacies 14.18. Rest of Middle East & Africa Geriatric Medicines Market Forecast, By Therapeutic Category 14.18.1. Analgesic 14.18.2. Antihypertensive 14.18.3. Statins 14.18.4. Antidiabetic 14.18.5. Proton Pump Inhibitor 14.18.6. Anticoagulant 14.18.7. Antipsychotic and Antidepressant 14.18.8. Others (include, anticholinergics, gastrointestinal, etc.) 14.19. Rest of Middle East & Africa Geriatric Medicines Market Forecast, By Condition 14.19.1. Cardiovascular 14.19.2. Arthritis 14.19.3. Diabetes 14.19.4. Neurological 14.19.5. Cancer 14.19.6. Osteoporosis 14.19.7. Respiratory 14.19.8. Others (include, Parkinson's disease, palliative care, etc.) 14.20. Rest of Middle East & Africa Geriatric Medicines Market Forecast, By Distribution Channel 14.20.1. Hospital Pharmacies 14.20.2. Retail Pharmacies 14.20.3. Online Pharmacies 14.21. Middle East & Africa Geriatric Medicines Market Attractiveness Analysis 14.21.1. By Therapeutic Category 14.21.2. By Condition 14.21.3. By Distribution Channel 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Geriatric Medicines Market Analysis 15.1. Key Findings 15.2. South America Geriatric Medicines Market Overview 15.3. South America Geriatric Medicines Market Value Share Analysis, By Therapeutic Category 15.4. South America Geriatric Medicines Market Forecast, By Therapeutic Category 15.4.1. Analgesic 15.4.2. Antihypertensive 15.4.3. Statins 15.4.4. Antidiabetic 15.4.5. Proton Pump Inhibitor 15.4.6. Anticoagulant 15.4.7. Antipsychotic and Antidepressant 15.4.8. Others (include, anticholinergics, gastrointestinal, etc.) 15.5. South America Geriatric Medicines Market Value Share Analysis, By Condition 15.6. South America Geriatric Medicines Market Forecast, By Condition 15.6.1. Cardiovascular 15.6.2. Arthritis 15.6.3. Diabetes 15.6.4. Neurological 15.6.5. Cancer 15.6.6. Osteoporosis 15.6.7. Respiratory 15.6.8. Others (include, Parkinson's disease, palliative care, etc.) 15.7. South America Geriatric Medicines Market Value Share Analysis, By Distribution Channel 15.8. South America Geriatric Medicines Market Forecast, By Distribution Channel 15.8.1. Hospital Pharmacies 15.8.2. Retail Pharmacies 15.8.3. Online Pharmacies 15.9. South America Geriatric Medicines Market Value Share Analysis, By Country 15.10. South America Geriatric Medicines Market Forecast, By Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Geriatric Medicines Market Analysis, By Country 15.12. Brazil Geriatric Medicines Market Forecast, By Therapeutic Category 15.12.1. Analgesic 15.12.2. Antihypertensive 15.12.3. Statins 15.12.4. Antidiabetic 15.12.5. Proton Pump Inhibitor 15.12.6. Anticoagulant 15.12.7. Antipsychotic and Antidepressant 15.12.8. Others (include, anticholinergics, gastrointestinal, etc.) 15.13. Brazil Geriatric Medicines Market Forecast, By Condition 15.13.1. Cardiovascular 15.13.2. Arthritis 15.13.3. Diabetes 15.13.4. Neurological 15.13.5. Cancer 15.13.6. Osteoporosis 15.13.7. Respiratory 15.13.8. Others (include, Parkinson's disease, palliative care, etc.) 15.14. Brazil Geriatric Medicines Market Forecast, By Distribution Channel 15.14.1. Hospital Pharmacies 15.14.2. Retail Pharmacies 15.14.3. Online Pharmacies 15.15. Mexico Geriatric Medicines Market Forecast, By Therapeutic Category 15.15.1. Analgesic 15.15.2. Antihypertensive 15.15.3. Statins 15.15.4. Antidiabetic 15.15.5. Proton Pump Inhibitor 15.15.6. Anticoagulant 15.15.7. Antipsychotic and Antidepressant 15.15.8. Others (include, anticholinergics, gastrointestinal, etc.) 15.16. Mexico Geriatric Medicines Market Forecast, By Condition 15.16.1. Cardiovascular 15.16.2. Arthritis 15.16.3. Diabetes 15.16.4. Neurological 15.16.5. Cancer 15.16.6. Osteoporosis 15.16.7. Respiratory 15.16.8. Others (include, Parkinson's disease, palliative care, etc.) 15.17. Mexico Geriatric Medicines Market Forecast, By Distribution Channel 15.17.1. Hospital Pharmacies 15.17.2. Retail Pharmacies 15.17.3. Online Pharmacies 15.18. Rest of South America Geriatric Medicines Market Forecast, By Therapeutic Category 15.18.1. Analgesic 15.18.2. Antihypertensive 15.18.3. Statins 15.18.4. Antidiabetic 15.18.5. Proton Pump Inhibitor 15.18.6. Anticoagulant 15.18.7. Antipsychotic and Antidepressant 15.18.8. Others (include, anticholinergics, gastrointestinal, etc.) 15.19. Rest of South America Geriatric Medicines Market Forecast, By Condition 15.19.1. Cardiovascular 15.19.2. Arthritis 15.19.3. Diabetes 15.19.4. Neurological 15.19.5. Cancer 15.19.6. Osteoporosis 15.19.7. Respiratory 15.19.8. Others (include, Parkinson's disease, palliative care, etc.) 15.20. Rest of South America Geriatric Medicines Market Forecast, By Distribution Channel 15.20.1. Hospital Pharmacies 15.20.2. Retail Pharmacies 15.20.3. Online Pharmacies 15.21. South America Geriatric Medicines Market Attractiveness Analysis 15.21.1. By Therapeutic Category 15.21.2. By Condition 15.21.3. By Distribution Channel 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Sunovion Pharmaceuticals Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. AstraZeneca 16.3.3. Novartis AG 16.3.4. F. Hoffmann-La Roche Ltd 16.3.5. GlaxoSmithKline plc. 16.3.6. Teva Pharmaceutical Industries Ltd. 16.3.7. Merck Sharp & Dohme Corp 16.3.8. Boehringer Ingelheim International GmbH. 16.3.9. Actelion Pharmaceuticals Ltd 16.3.10. Bayer AG 16.3.11. Sanofi SA 16.3.12. Meda Pharmaceuticals 16.3.13. Circassia Pharmaceuticals Plc. 16.3.14. Mallinckrodt Pharmaceuticals Plc. 16.3.15. Cheisi Farmaceutici S.p.A 16.3.16. Zambon Company S.p.A 16.3.17. Alaxia SAS 16.3.18. Allergan Inc. 16.3.19. Endo Pharmaceuticals Inc. 16.3.20. Otsuka Pharmaceutical Co., Ltd 16.3.21. Dr. Reddy's Laboratories Ltd 16.3.22. Sun Pharmaceutical Industries Ltd 16.3.23. Mylan N.V. 16.3.24. Aurobindo Pharma 17. Primary Key Insights